New #Stocks and #Trading Ideas: (Nasdaq: $DARE) (Nasdaq: $DCGO) (CSE: $GAMA.C) (TSX: $ANRG.TO) TSXV: $PINK.V) (TSXV: $DMT.V)
New Stocks to Watch in #Biotech, #Mining and #Cleantech
Vancouver, Kelowna, Delta, BC, April 29, 2022 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Biotech, Mining and Cleantech. Today’s stocks have been added to our lists of free stock directories in each sector.
Read this in full at https://www.investorideas.com/news/2022/main/04291Stocks.asp
Investor Ideas also recently added a new Retail Stocks List – see the news at https://www.investorideas.com/news/2022/main/04255Retail-Stocks-List.asp
The newest biotech companies are involved in biopharma, life sciences, medical devices, telehealth, Covid-19 treatment and psychedelics.
The latest mining companies are all Canadian-based and the newest cleantech company operates an organic waste to energy process.
New Stocks added to the Biotech Stocks Directory:
Dare Biosciences (Nasdaq:DARE) is a biopharmaceutical company committed to advancing innovative products for women’s health. The company’s mission is to identify, develop and bring to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, primarily in the areas of contraception, fertility, and vaginal and sexual health.
Adaptimmune Therapeutics plc (NasdaqGS:ADAP) is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for people with cancer. The Company’s unique SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platform enables the engineering of T-cells to target and destroy cancer across multiple solid tumors.
DocGo (Nasdaq:DCGO) is a leading provider of last-mile mobile care services and integrated medical mobility solutions. DocGo is disrupting the traditional four-wall healthcare system by providing high quality, highly affordable care to patients where and when they need it. DocGo's innovative technology and dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks, and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient's home or workplace. Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care.
Lumos Pharma, Inc. (NasdaqGM:LUMO) is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare diseases. Lumos Pharma was founded and is led by a management team with longstanding experience in rare disease drug development and received early funding from leading healthcare investors, including Deerfield Management, a fund managed by Blackstone Life Sciences, Roche Venture Fund, New Enterprise Associates (NEA), Santé Ventures, and UCB. Lumos Pharma’s lead therapeutic candidate is LUM-201, an oral growth hormone stimulating small molecule, currently being evaluated in a Phase 2 clinical trial, the OraGrowtH210 Trial, and a PK/PD trial, the OraGrowtH212 Trial, for the treatment of Pediatric Growth Hormone Deficiency (PGHD). If approved by the FDA, LUM-201 would provide an orally administered alternative to recombinant growth hormone injections that PGHD patients otherwise endure for many years of treatment. LUM-201 has received Orphan Drug Designation in both the US and EU
Awakn Life Sciences Corp. (NEO: AWKN) (OTC:AWKNF) is a biotechnology company, researching, developing, and delivering revolutionary therapeutics to treat addiction. Awakn's team consists of renowned research experts and world leading chemists, scientists, psychiatrists, and psychologists. Addiction is one of the biggest unmet medical needs of our time, affecting over 20% of the global population and is an industry valued at over $100bn per annum. Awakn is disrupting this underperforming industry by rapidly advancing the next generation of psychedelic drugs and therapies to be used in combination, through preclinical research and clinical stage trials.
Monopar Therapeutics, Inc. (Nasdaq:MNPR) is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The Company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients; camsirubicin for the treatment of advanced soft tissue sarcoma; a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19; and an early-stage camsirubicin analog, MNPR-202, for various cancers.
Perimeter Medical Imaging, Inc AI (TSXV:PINK; OTC:PYNKF) s a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated, investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that is currently under clinical development.
Journey Medical Corp. (Nasdaq:DERM) is focused on identifying, acquiring, developing and strategically commercializing innovative, differentiated dermatology products through its efficient sales and marketing model. The company currently markets nine products that help treat and heal common skin conditions. The Journey Medical team is comprised of industry experts with extensive experience in developing and commercializing some of the most successful prescription dermatology brands. Journey Medical is located in Scottsdale, Arizona
P3 Health Partners (Nasdaq:PIII) is a patient-centered and physician-led population health management company. Founded and led by physicians, P3 is a team of doctors, clinicians and support service professionals with a shared passion for delivering value-based care. We leverage our deeply integrated and capital efficient care model, data and technology, physician leadership and community outreach tools to create enhanced patient outcomes and experiences, greater satisfaction for providers and caregivers and lower care costs
Small Pharma Inc. (TSXV:DMT) is a neuroscience company specialized in discovering and developing novel treatments for mental health conditions, with a current focus on depression. Small Pharma initiated a clinical program into DMT-assisted therapy in February 2021. This program includes a Phase I/IIa trial on the Company’s lead candidate alongside development of a robust pipeline of proprietary preclinical assets. DMT is a naturally occurring psychedelic tryptamine found in plants and in the brain of mammals. Scientific evidence suggests DMT offers the potential for rapid-acting and long-lasting antidepressant effects.
RenovoRx, Inc. (NasdaqCM:RNXT) is a clinical-stage biopharmaceutical company focused on fighting cancer through the localized treatment of difficult to treat tumors via its proprietary RenovoRx Trans-Arterial Micro-Perfusion (RenovoTAMP™) therapy platform. RenovoTAMP utilizes approved chemotherapeutics with validated mechanisms of action and well-established safety and side effect profiles, with the goal of increasing their efficacy, improving their safety, and widening their therapeutic window. RenovoRx’s lead product candidate, RenovoGem™, is a combination of gemcitabine and our patented delivery system, RenovoCath®, and is regulated by the FDA as a novel oncology drug product to treat unresectable locally advanced pancreatic cancer (LAPC). RenovoGem is currently being studied in the Phase 3 TIGeR-PaC trial for the treatment of LAPC. RenovoRx’s patent portfolio for its therapy platform and product candidates includes seven U.S. patents, one European patent and several additional patents pending in the US, EU and Asia. RenovoRx has been granted Orphan Drug Designation for intra-arterial delivery of gemcitabine for the treatment of both pancreatic cancer and bile duct cancer. RenovoRx won the Drug Delivery Technology category of the Fierce Innovation Awards – Life Sciences Edition 2020 for its RenovoTAMP technology.
Panbela Therapeutics (NASDAQ:PBLA) is a clinical-stage biopharmaceutical company developing disruptive therapeutics for patients with urgent unmet medical needs. The company’s initial product candidate, SBP-101, is for the treatment of patients with metastatic pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer. Panbela Therapeutics, Inc. is dedicated to treating patients with pancreatic cancer, ovarian cancer, and exploring SBP-101’s potential for efficacy in combination with other agents in other cancer indications.
Marker Therapeutics, Inc. (Nasdaq:MRKR) is a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Marker’s cell therapy technology is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens (i.e. tumor targets) and kill tumor cells expressing those targets. This population of T cells is designed to attack multiple tumor targets following infusion into patients and to activate the patient’s immune system to produce broad spectrum anti-tumor activity. Because Marker does not genetically engineer its T cell therapies, we believe that our product candidates will be easier and less expensive to manufacture, with reduced toxicities, compared to current engineered CAR-T and TCR-based approaches, and may provide patients with meaningful clinical benefit. As a result, Marker believes its portfolio of T cell therapies has a compelling product profile, as compared to current gene-modified CAR-T and TCR-based therapies.
Dynatronics Corporation (NasdaqCM:DYNT) is a leading medical device company committed to providing high-quality restorative products designed to accelerate achieving optimal health. The Company designs, manufactures and sells a broad range of products for clinical use in physical therapy, rehabilitation, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and consumers. The Company's products are marketed under a portfolio of high-quality, well-known industry brands including Bird & Cronin®, Solaris™, Hausmann®, Physician's Choice®, and PROTEAM™, among others
Aravive, Inc. (Nasdaq:ARAV) is a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease. Our lead product candidate, batiraxcept (formerly AVB-500), is an ultra-high affinity decoy protein that binds to GAS6, the sole ligand that activates AXL, thereby inhibiting metastasis and tumor growth, and restoring sensitivity to anti-cancer agents. Batiraxcept has been granted Fast Track Designation by the U.S. FDA and Orphan Drug Designation by the European Commission in platinum-resistant recurrent ovarian cancer. Batiraxcept is in an active registrational Phase 3 trial in platinum resistant ovarian cancer (NCT04729608), a Phase 1b/2 trial in clear cell renal cell carcinoma (NCT04300140), and a Phase 1b/2 trial in pancreatic adenocarcinoma (NCT04983407).
New Stocks added to the Mining Stocks Directory:
Pacton Gold Inc. (TSXV:PAC) is a Canadian exploration company with key strategic partners focused on the exploration and development of high-grade gold properties located in the Red Lake gold rush in Ontario, Canada. The Company also owns a strategic portfolio of prospective projects in the district-scale Pilbara gold rush in Western Australia.
Gama Explorations Inc. (CSE:GAMA) is a Canadian company listed on the Canadian Stock Exchange. The Company is a mineral exploration company focused on the acquisition, exploration and development of properties for the mining of copper. The company currently has the right to acquire 100% interest in the property known as the Big Onion Project located a short 20-minute drive from the town of Smithers in northern British Columbia. The Company’s objective is to explore and, if warranted, develop the Big Onion Property. It is the intention of the Company to remain in the mineral exploration business. The Company will evaluate opportunities to acquire interest in additional exploration stage mineral properties.
Prudent Minerals Corp. (CSE: PRUD) is an exploration stage natural resource company engaged in the evaluation, acquisition and exploration of mineral resource properties with the intention, if warranted, of placing them into production. Prudent currently has an option to acquire a 100% interest in its principal project, the SAT Property, a series of copper prospective claims located in west‑central British Columbia, approximately 10 kilometres west of the town of Granisle, British Columbia.
New Stocks added to the Cleantech Stocks Directory:
Anaergia Inc. (TSX:ANRG.TO) was created to eliminate a major source of greenhouse gases ("GHGs") by cost effectively turning organic waste into renewable natural gas ("RNG"), fertilizer and water, using proprietary technologies. With a proven track record from delivering world-leading projects on four continents, Anaergia is uniquely positioned to provide end-to-end solutions for extracting organics from waste, implementing high efficiency anaerobic digestion, upgrading biogas, producing fertilizer and cleaning water. Our customers are in the municipal solid waste, municipal wastewater, agriculture, and food processing industries. In each of these markets Anaergia has built many successful plants including some of the largest in the world. Anaergia owns and operates some of the plants it builds, and it also operates plants that are owned by its customers.
The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast , Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and the AI Eye Podcast.
Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com
Learn more about advertising and guest posts
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
800 665 0411
Sol Systems LLC has acquired a 37 MW DC solar development project in Morgan County, Ill., from Lightrock Power. Sol Systems acquired the project through an RFP process executed on LevelTen Energy’s Asset Marketplace and it is part of Sol Systems’ growth strategy to scale its Impact + Infrastructure platform across the U.S. “This acquisition […]
The post Lightrock Sells 37 MW Prairie Creek to Sol Systems Through LevelTen Marketplace appeared first on Solar Industry.
Department of Commerce AD/CVD Circumvention Inquiry
The post Department of Commerce AD/CVD Circumvention Inquiry appeared first on ACORE.
Duke Energy Sustainable Solutions, a nonregulated commercial brand of Duke Energy, has started construction of the 120 MW Jackpot Solar project in Twin Falls County, Idaho. This is the organization’s first utility-scale renewable energy project in the state, and once complete, it will be the largest solar facility in operation in Idaho. Jackpot Solar, which […]
The post Duke Energy Begins Jackpot Solar Construction with Idaho Power PPA in Place appeared first on Solar Industry.
DSD Renewables (DSD) and Caesars Entertainment have broken ground on an 8.4 MW solar portfolio spanning three Caesars properties in Atlantic City, N.J. The projects will help propel Caesars toward its goal of reducing greenhouse gas emissions by 100% before 2050. The portfolio includes two solar canopies (1.7 MW and 886 kW) at Caesars Atlantic […]
The post DSD, Caesars Start Installation of Solar Portfolio in Atlantic City appeared first on Solar Industry.
Solar installation forecasts for 2022 and 2023 are being cut by 46% due to the Biden administration’s circumvention case against solar imports from Southeast Asia. According to a new analysis by the Solar Energy Industries Association (SEIA), the case will result in a drop of 24 GW of planned solar capacity over the next two […]
The post U.S. Tariff Case Could Jeopardize 100,000 Solar Jobs appeared first on Solar Industry.
Florida Gov. Ron DeSantis has vetoed the recently passed CS/CS/HB 741 – Net Metering bill, which requires the Public Service Commission (PSC) to revise its rules on net metering of customer renewable generation, effective January 1, 2024. The revised rule must provide that excess electricity used by the customer is billed in accordance with normal […]
Energy storage solutions provider Convergent Energy + Power has begun operation of three more Maryland-based solar-plus-storage systems developed for Choptank Electrical Cooperative. These systems are in addition to the two systems Convergent has been operating for the utility since 2019. These new systems add 4 MW/8 MWh of storage and over 2 MW of solar […]
The post Convergent Powers Additional Solar+Storage Systems in Maryland appeared first on Solar Industry.
#Solar/#EV #Stock News - Solar Integrated Roofing (OTC: $SIRC) Subsidiary PLEMCo Awarded 5 Year EV Charging Contract with General Services Administration; @SIRCStock
Contract to Service $5 Billion #ElectricVehicle Supply Equipment (EVSE) Federal Stimulus Opportunity
PLEMCO, Part of the SIRC Family of Companies, One of Sixteen Firms in the US to Receive Federal Blanket Purchase Agreement
Read this news, featuring SRIC in full at https://www.investorideas.com/news/2022/renewable-energy/04281SIRC-PLEMCo.asp
One of the bipartisan Infrastructure Bill’s stated goals is to install EV Charging Stations every 50 miles along the interstate system. Although each state will establish its own priorities and allocate infrastructure funds, all spending at the Federal, State, Local, and Department level for government funded Electric Vehicle Supply Equipment (EVSE) will be bid and awarded through the GSA. Installation may be done by government entities, contracted out through a secondary bid process or by utilities.
PLEMCo’s award is a five year Design and Material only contract for Level 2 and Level 3 EV chargers. A second EVSE – BPA is currently being submitted that will include Design, Equipment, and Installation of EV Chargers, which is expected to be awarded by July.
“We are privileged to be one of only 16 companies in the United States authorized to potentially supply over 500,000 EV charging stations across the country over the next decade,” said David Massey, Chief Executive Officer of Solar Integrated Roofing Corp. “These stations are set to supercharge the increasingly widespread adoption of electric vehicles by consumers and fleets through providing charging stations across the interstate system and filling in current gaps of service.
“We continue to see significant industry tailwinds, as California has announced they will discontinue the sale of internal combustion engine (“ICE”) vehicles by 2035, potentially requiring 1.2 million EV Charging station installations to be completed to support the transition. Washington State has also announced an intention to eliminate ICE vehicles sales even earlier, by 2030. Taken together, the EV charging market is expected to surpass the $28.4 billion mark by 2028 and continue upwards – an exciting opportunity for us to empower through charging installations.
“This contract further supports our strategic shift towards prioritizing our over $30 million electric vehicle (EV) charging project pipeline and over $20 million EV charging project backlog given the immense near-term opportunities. This will serve to further bolster our position as a clear national player in the space, helping to create sustainable value for our shareholders. We look forward to additional announcements regarding EV charging opportunities in the months ahead,” concluded Massey.
About Solar Integrated Roofing Corp.
Solar Integrated Roofing Corp. (OTC: SIRC), is an integrated, single-source solar power, roofing systems installation and EV charging company specializing in commercial and residential properties throughout the United States. The Company serves communities by delivering the best experience through constant innovation & legacy-focused leadership. The Company's broad array of solutions include sales and installation of solar energy systems, battery backup and electric vehicle (EV) charging stations to roofing, HVAC and related electrical contracting work. For more information, please visit the Company's website at www.solarintegratedroofing.com or join us on Twitter, Facebook or Discord.
Any statements made in this press release which are not historical facts contain certain forward-looking statements; as such term is defined in the Private Security Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. The actual results of the specific items described in this release, and the company's operations generally, may differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company's dependence on third parties, general market and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the company. The company disclaims any obligation to update the information contained in any forward-looking statement. This press release shall not be deemed a general solicitation.
Paid News -Disclaimer/Disclosure: . Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure : this news release featuring SIRC is a paid for news release on Investorideas.com More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Investorideas.com is a recognized news source in the financial markets for over 25 years. We were one of the first retail investor sites to cover renewable energy and cleantech stocks at investorideas.com and our domain Renewableenergystocks.
Sign up for free stock news alerts at Investorideas.com
|cookielawinfo-checkbox-analytics||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".|
|cookielawinfo-checkbox-functional||11 months||The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".|
|cookielawinfo-checkbox-necessary||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".|
|cookielawinfo-checkbox-others||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.|
|cookielawinfo-checkbox-performance||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".|